Watanabe A, Nishida S, Burcu T, Shibahara T, et al. Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-beta-cyclodextrin: A phase 1 clinical trial. Vaccine 2022 Jun 4. pii: S0264-410X(22)00677.
PMID: 35672178